Mustang Bio Announces City of Hope Opens First-of-Its-Kind Multiple Myeloma CAR T Cell Therapy Trial Targeting CS1 Protein
Mustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T) for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
Bold Reports Positive Results of Induced Polarization Survey at Joutel - Signs Investor Awareness Agreement
SAGA Metals Highlights Historic $70 Billion Clean Energy Investment and Strategic Infrastructure Commitments in Labrador
Prince Silver Builds Momentum Toward Maiden Mineral Resource Estimate After Completing More than 10,000 m of Drilling
